Sort by
Refine Your Search
-
NIST only participates in the February and August reviews. While natural and anthropogenic contaminants threaten existing freshwater supplies, the use of alternative, “dirty” sources is increasing
-
reformulation is often impossible without new, costly clinical trials. In order to improve formulations and/or make reformulation possible, it is necessary to characterize the biologically active state and to
-
@nist.gov 301.975.6832 Description The goal of this research is to advance vibrational spectroscopy techniques for selective and sensitive characterization of the higher order structure (HOS) of proteins
-
daniel.sunday@nist.gov 301 975 4921 Description Conventional optical-based photolithography is reaching the limits of scaling for the patterning and fabrication of nanoscale devices. The semiconductor industry
-
. The established uncertainty benchmark for absolute JNT is 12 ppm at the triple point of water (273.15 K), with more recent measurements achieving statistical uncertainties of 3 ppm. For temperatures in the range
-
and novel data-processing tools need to be developed to embrace these new techniques and further elevate their capabilities. Instrumentation available for this research includes ion trap, Orbitrap, and
-
NIST only participates in the February and August reviews. The Alternative Computing Group at NIST has an ongoing program developing new metrologies to support emerging information processing
-
NIST only participates in the February and August reviews. Accurate measurement of optical radiation is important for the optical communications, medical device, semiconductor lithography
-
pushed the limits of mass detection to spectral resolutions over 100,000, allowing for specific mass determination and unknown compound identification. Analytical methods and novel data-processing tools
-
Bergonzo christina.bergonzo@nist.gov (240)314 6333 John P. Marino john.marino@nist.gov 240.314.6361 Description There has been a recent emergence of RNA biotherapeutics; that is, small RNAs used as drug